The groundbreaking therapy of this peptide represents a major development in the care of diabetes mellitus type 2. Unlike existing medications, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide533183.ltfblog.com/40469001/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment